BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6881330)

  • 1. Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog.
    Hagopian W; Lever EG; Cohen D; Emmanouel D; Polonsky KS; Pugh W; Moossa A; Jaspan JB
    Am J Physiol; 1983 Aug; 245(2):E171-7. PubMed ID: 6881330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog.
    Polonsky KS; Jaspan JB; Berelowitz M; Emmanouel DS; Dhorajiwala J
    J Clin Invest; 1981 Nov; 68(5):1149-57. PubMed ID: 6117570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic hormone profiles and metabolism posthepatectomy in the dog. Evidence for a hepatotrophic role of insulin, glucagon, and pancreatic polypeptide.
    Cohen DM; Jaspan JB; Polonsky KS; Lever EG; Moossa AR
    Gastroenterology; 1984 Sep; 87(3):679-87. PubMed ID: 6146553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism.
    Polonsky K; Jaspan J; Emmanouel D; Holmes K; Moossa AR
    Acta Endocrinol (Copenh); 1983 Mar; 102(3):420-7. PubMed ID: 6338678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pancreatic polypeptide in chronic renal failure and cirrhosis of the liver: role of kidneys and liver in pancreatic polypeptide metabolism.
    Boden G; Master RW; Owen OE; Rudnick MR
    J Clin Endocrinol Metab; 1980 Sep; 51(3):573-8. PubMed ID: 7410534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of proinsulin, insulin, and C-peptide in the rat.
    Katz AI; Rubenstein AH
    J Clin Invest; 1973 May; 52(5):1113-21. PubMed ID: 4700486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of neurotensin and pancreatic polypeptide in man: role of the kidney and plasma factors.
    Shulkes A; Bijaphala S; Dawborn JK; Fletcher DR; Hardy KJ
    J Clin Endocrinol Metab; 1984 May; 58(5):873-9. PubMed ID: 6707191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of hepatic extraction of pancreatic polypeptide in conscious dogs.
    Ishida T; Chou MC; Chou J; Lewis RM; Hartley CJ; Entman M; Kimmel JR; Field JB
    Am J Physiol; 1983 Oct; 245(4):E401-9. PubMed ID: 6624908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of pancreatic polypeptide in man.
    Adrian TE; Greenberg GR; Besterman HS; Bloom SR
    Gut; 1978 Oct; 19(10):907-9. PubMed ID: 568585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.
    Polonsky K; Jaspan J; Pugh W; Cohen D; Schneider M; Schwartz T; Moossa AR; Tager H; Rubenstein AH
    J Clin Invest; 1983 Sep; 72(3):1114-23. PubMed ID: 6350363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon metabolism in the rat.
    Emmanouel DS; Jaspan JB; Rubenstein AH; Huen AH; Fink E; Katz AI
    J Clin Invest; 1978 Jul; 62(1):6-13. PubMed ID: 659638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study.
    Ferrannini E; Wahren J; Faber OK; Felig P; Binder C; DeFronzo RA
    Am J Physiol; 1983 Jun; 244(6):E517-27. PubMed ID: 6344651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon.
    Jaspan JB; Polonsky KS; Lewis M; Pensler J; Pugh W; Moossa AR; Rubenstein AH
    Am J Physiol; 1981 Mar; 240(3):E233-44. PubMed ID: 7011049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic polypeptide. Metabolism and effect on pancreatic secretion in dogs.
    Taylor IL; Solomon TE; Walsh JH; Grossman MI
    Gastroenterology; 1979 Mar; 76(3):524-8. PubMed ID: 428706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous pancreatic polypeptide in different vascular beds: relationship to release and degradation in subjects with normal and decreased kidney function.
    Henriksen JH; Schwartz TW; Bülow JB
    Metabolism; 1986 Jun; 35(6):542-6. PubMed ID: 3713514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and cerebroventricular fluid levels of pancreatic polypeptide in the dog: effects of feeding, insulin-induced hypoglycemia, and physical exercise.
    Inui A; Okita M; Miura M; Hirosue Y; Mizuno N; Baba S; Kasuga M
    Endocrinology; 1993 Mar; 132(3):1235-9. PubMed ID: 8440184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure.
    Hruska KA; Korkor A; Martin K; Slatopolsky E
    J Clin Invest; 1981 Mar; 67(3):885-92. PubMed ID: 7204561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of in vitro hepatic insulin resistance in chronic pancreatitis by pancreatic polypeptide in the rat.
    Goldstein JA; Kirwin JD; Seymour NE; Trachtenberg JE; Rademaker EA; Andersen DK
    Surgery; 1989 Dec; 106(6):1128-32; discussion 1132-3. PubMed ID: 2588116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.